2026 data FDA MAUDE openFDA

Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Nad Reduction/Nadh Oxidation LIGHT-BOOK · MAUDE

#555 of 1000 · 1,513 reports · 2007–2026

  • BOOK 1,513 reports
  • RANK #555 of 1000
  • DEATH 0 death-typed
  • INJ 2 injury-typed
  • MALF 1,510 malfunction
  • SPAN 2007–2026
  • PEAK 2018: 1,434
  • PHOTO Calculator, Drug Dose

Nearest event-volume peer: Calculator, Drug Dose (1 report gap)

Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes sits #555 of 1000 among tracked device types with 1,513 MAUDE reports spanning 2007–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Event-type mix vs corpus

Shares of FDA event_type codes on this device type, compared with the mean across 1,000 device types that have ≥100 MAUDE reports. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 0.1% corpus 30.4% · below corpus mean (-30.3 pp)
  • MALF 99.8% corpus 64.5% · above corpus mean (+35.3 pp)

Lead product-problem code Unable to Obtain Readings is 87% of coded problems · Lead manufacturer ABBOTT MANUFACTURING INC accounts for 96% of manufacturer-tagged reports · Top event location I is 95% of location-tagged rows .

Nad Reduction/Nadh Oxidation in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes carries 1,513 MAUDE reports, ranked #555 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 1,510 (99.8%)
Injury 2 (0.1%)
1 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

1,509 (99.7%)
Congenital Anomaly 2 (0.1%)
Other 2 (0.1%)

Top Product Problems

Unable to Obtain Readings 1,358
Low Test Results 192
High Test Results 1
Human Factors Issue 1
Patient-Device Incompatibility 1

Yearly Trend

07
2007: 64
10
2010: 1
11
2011: 3
17
2017: 2
18
2018: 1,434
19
2019: 4
22
2022: 1
24
2024: 1
25
2025: 2
26
2026: 1

Related Entities for Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes

Event Locations

I 1,440 (95.2%)
72 (4.8%)
LABORATORY 1 (0.1%)

Compare ABBOTT MANUFACTURING INC vs ABBOTT MANUFACTURING, INC. →

Nationwide devices with similar MAUDE profiles

Two openFDA-derived peer sets for Nad Reduction/Nadh Oxidation, both floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (1,513 here).

Similar death-typed counts

Nearest other device types by death-typed report count (0 here), distinct from the volume row.

Disclaimer: MAUDE figures for Nad Reduction/Nadh Oxidation are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Nad Reduction/Nadh Oxidation; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.